Sunovion Announces Acceptance by the U.S. FDA of the New Drug Application for Dasotraline for the Treatment of Adults with Moderate-to-Severe Binge Eating Disorder
–Binge eating disorder (BED) is estimated to affect 4.1 million Americans and may occur at a rate that is three…